Top 3 Canadian Cannabis Stocks to Watch in October 2025The Canadian cannabis sector continues to attract attention as investors look for opportunities amid renewed optimism surrounding U.S. legalization. The U.S. cannabis industry is projected to exceed $40 billion in annual sales by 2026, reflecting steady growth despite regulatory delays. Recent headlines about federal rescheduling discussions and state-level legalization measures have reignited momentum across both Canadian and American operators. As a r ...

Redhook 81, a Cold One for Quittin’ TimeSEATTLE, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Redhook Brewing, creator of the hardest working beer in the fridge and a craft brand by Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the cannabis, beverage, and wellness industries, is proud to introduce Redhook 81, a crisp, no-nonsense light lager brewed for the end of the shift and the start of happy hour. Redhook 81 is a 4.2% ABV light lager ...

We came across a bullish thesis on Tilray Brands, Inc. on Value investing subreddit by MarketFlux. In this article, we will summarize the bulls’ thesis on TLRY. Tilray Brands, Inc.'s share was trading at $2.1000 as of October 9th. TLRY’s trailing P/E was 57.50 according to Yahoo Finance. Top 20 Countries With The Highest Weed Consumption Top 20 Countries With The Highest Weed Consumption Tilray Brands (TLRY) has spent the past year executing a deliberate strategy of diversification and international exp ...

The cannabis stock is up 20% this year, and that's a phenomenal performance by its standards.Tilray Brands (TLRY 5.73%) is a leading cannabis producer in Canada, and it's been seven years since the country legalized marijuana for recreational use. Since then, however, Tilray's stock has been in a persistent tailspin. As competition intensified in the Canadian cannabis market and growth became more difficult, investors turned bearish on stocks like Tilray.This year, however, things have been looking much bet ...

Maybe it's best to cut your losses and move on.While it has been a volatile ride due to the pandemic, economic challenges, and geopolitical instability, the stock market has delivered strong returns over the past five years. Plenty of companies have failed to keep up with this pace, though. One of them is Tilray Brands (TLRY 0.96%), a leader in the cannabis industry. A wealth destroyerSince 2020 (and even before), Tilray's financial results have been unimpressive, at best. The company faced significant chal ...

Core Insights - Tilray Brands, Inc. celebrates the seventh anniversary of cannabis legalization in Canada, highlighting the country's role as the largest federally legal cannabis market globally and its progressive regulatory framework that fosters innovation and economic opportunities [1][2] Company Overview - Tilray is a global lifestyle and consumer packaged goods company operating in the cannabis, beverage, and wellness industries, with a mission to inspire joy and create memorable experiences through its diverse brand portfolio [8] Economic Impact - The company has invested over C$1 billion in Canadian infrastructure, paid approximately C$700 million in excise taxes, and contributed hundreds of millions in various taxes, significantly legitimizing the cannabis industry and supporting local economies [2][4] Market Position - Tilray holds the leading sales position in several cannabis categories, including pre-rolls, beverages, oils, and chocolate edibles, and has achieved the strongest quarter-over-quarter growth among the top five Canadian cannabis producers [4][5] Product Innovation - The company operates 15 leading cannabis brands in Canada, with several valued between C$100 million and C$300 million, and is recognized for pioneering new product innovations such as THC/CBD-infused beverages and shareable edibles [3][5] Future Growth Opportunities - Tilray aims to capitalize on future industry growth through expanding cannabis in healthcare, on-premise consumption of THC beverages, and regulatory modernization to enhance competitiveness and innovation [6][7] Infrastructure and Capacity - The company has 5 million square feet of advanced cannabis cultivation facilities and a current production capacity of 210 metric tons, with significant expansion capabilities to meet rising demand [7] Global Expansion - As regulatory landscapes evolve in Europe and the United States, Tilray is well-positioned to seize new opportunities and establish a leading presence in these emerging markets, reinforcing its status as a global cannabis industry leader [7]

Core Insights - Tilray Brands, Inc. celebrates the seventh anniversary of cannabis legalization in Canada, highlighting the country's role as the largest federally legal cannabis market globally and its progressive regulatory framework that fosters innovation and economic opportunities [1][2] Company Overview - Tilray is a global lifestyle and consumer packaged goods company operating in the cannabis, beverage, and wellness industries, with a mission to be a leading premium lifestyle company [8] - The company has invested over C$1 billion in Canadian infrastructure and paid approximately C$700 million in excise taxes, contributing significantly to the economy [2] Market Position - Tilray is recognized as Canada's largest legal cannabis company by revenue, leading in various product categories including pre-rolls, beverages, oils, and chocolate edibles [4] - The company holds over 40% market share in THC beverages through its XMG and Mollo brands, and its edibles brand, Chowie Wowie, is noted for its quality [5] Innovation and Product Development - Tilray operates 15 leading cannabis brands in Canada, with several valued between C$100 million and C$300 million at retail, and is known for pioneering new product innovations [3] - The company has adopted advanced agronomic techniques for greenhouse cannabis cultivation, maintaining one of the industry's lowest cost structures while producing high-quality products [3] Future Growth Opportunities - The company aims to expand cannabis in healthcare and promote on-premise consumption of THC beverages, which could drive future growth [6] - Tilray's infrastructure includes 5 million square feet of advanced cultivation facilities and a production capacity of 210 metric tons, positioning it well to respond to rising demand [7]

Core Viewpoint - Tilray Brands has experienced a significant recovery in its stock price over the past six months, with shares up nearly 25% year to date, driven by positive developments in the cannabis industry and a better-than-expected quarterly earnings report [1][2][4]. Financial Performance - For the first quarter of fiscal year 2026, Tilray reported a revenue increase of 5% year over year, reaching $209.5 million. The company also recorded a net income of $1.5 million, marking a notable shift from its previous net losses [4]. Market Sentiment and Regulatory Environment - Speculation regarding potential legal changes in the U.S. cannabis industry, particularly the possible reclassification of cannabis from Schedule 1 to Schedule 3, has contributed to the positive market sentiment surrounding Tilray [2]. - The company is seen as a leading player in the cannabis sector, benefiting from the news related to cannabis reclassification, which could ease funding challenges for growers [2]. Challenges and Future Outlook - Despite recent gains, Tilray faces challenges, including plans to raise up to $51.6 million by selling additional shares, which may dilute existing shareholders. This highlights ongoing financial difficulties [5]. - The long-term outlook for Tilray's stock remains uncertain, with indications that it may not deliver strong returns despite recent momentum [6].

Group 1 - The U.S. stock market showed interest in Tilray Brands, with shares rising by 5%, outperforming the S&P 500 index which increased by 0.4% [1] - Stock prices of marijuana companies like Tilray often react positively to medical testing results or movements towards legalization [2] - A study from researchers at the University of Georgia and University of Colorado indicated that states with lenient cannabis laws saw a significant reduction in opioid prescriptions, with an average decline of 16% and some states reaching 22% [3][4] Group 2 - The findings from the study support the argument for cannabis as a beneficial treatment, which could encourage politicians to reform federal laws prohibiting it, potentially improving the fortunes of Tilray and the cannabis industry [5] - New research suggests that legalized cannabis could replace harmful opioids, strengthening the case for its de facto legalization [6] - The Motley Fool Stock Advisor analyst team has identified 10 stocks they believe are better investment options than Tilray Brands [7]

Tilray Brands Inc (NASDAQ:TLRY) shares are trading higher on Wednesday after a Marijuana Moment report cited findings from a new study showing medical cannabis legalization leads to significant reductions in opioid prescriptions. Here’s what investors need to know. • TLRY is among today’s top performers. Stay ahead of the curve here.What To Know: A study in the American Journal of Health Economics found medical cannabis legalization is "associated with significant reductions in opioid prescribing.”Analyzing ...